| |
|
| |
 |
|
Peter M. Hecht, Ph.D.
Chief Executive Officer |
|
Brian M. Cali, Ph.D.
Vice President, Preclinical R&D |
|
Mark G. Currie, Ph.D.
Senior Vice President, Chief Scientific Officer, and President of R&D |
| Mark G. Currie serves as Ironwood’s senior vice president, chief scientific officer, and president of research and development. He has led the Company’s R&D efforts since joining Ironwood in 2002. Prior to joining Ironwood, he directed cardiovascular and central nervous system disease research as vice president of discovery research at Sepracor Inc. Previously, Dr. Currie initiated, built, and led discovery pharmacology and also served as director of arthritis and inflammation at Monsanto Company. Dr. Currie earned a B.S. in biology from the University of South Alabama and holds a Ph.D. in cell biology from the Bowman-Gray School of Medicine of Wake Forest University. |
|
James M. DeTore
Vice President, Finance and Administration |
|
Halley Gilbert, Esq.
Vice President, Legal Affairs and General Counsel |
|
Michael J. Higgins
Chief Operating Officer and Chief Financial Officer |
|
Thomas McCourt
Chief Commercial Officer and
Senior Vice President, Marketing and Sales |
|
G. Todd Milne, Ph.D.
Vice President, Biology |
|
James J. O'Mara
Vice President, Corporate Development |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
